Annual report
2374.TEDINET S100W4JA
Period2024-04-01 → 2025-03-31
Filed2025-06-25
StandardJapan GAAP
ConsolidatedYes
Data checks22 of 24 passed
Key figures · 160
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥56.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥54.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥52.6bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥48.9bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥45.9bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.4bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥3.0bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥2.5bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.2bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.7bn | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.8bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.8bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.5bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.2bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.0bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.7bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.8bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.5bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥2.0bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥30.5bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥31.0bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥29.5bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥27.5bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥26.0bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥13.6bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥14.9bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥16.9bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥16.1bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥14.6bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥13.7bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥12.2bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.2bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥8.0bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥7.2bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.0bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.7bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.6bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥5.8bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.0bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.6bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥994m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥715m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.6bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥692m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥199m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.1bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥60.33 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥81.15 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥68.87 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥73.54 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.61 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥59.73 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥80.34 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥68.18 | 2022-04-01 → 2023-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥72.81 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥58.98 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥681.27 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥646.79 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥589.7 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥543.39 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥487.41 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 55.1% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.6% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.3% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.4% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.8% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 9.1% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.1% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.2% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.3% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.8% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 5,033 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 4,738 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 4,689 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 4,423 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 3,926 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥3.1bn | 2024-04-01 → 2025-03-31 | Standalone | Operating revenue2 |
| Revenue | ¥3.8bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.0bn | 2023-04-01 → 2024-03-31 | Standalone | Operating revenue2 |
| Revenue | ¥3.6bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.1bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.0bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.4bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥915m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥1.1bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥915m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.1bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.8bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥905m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.1bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥763m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥888m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥1.5bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.5bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥670m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥16.2bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥16.7bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥16.8bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥14.8bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥14.1bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥4.5bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.1bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥11.7bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥11.6bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥11.3bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥10.6bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥9.5bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4.5bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥5.1bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥30.95 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.92 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.8 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥58.94 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.86 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥30.64 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥35.56 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥59.21 | 2022-04-01 → 2023-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥58.36 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.57 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥30 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥25 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥472.11 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥467.47 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥455.28 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥419.81 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥376.5 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 71.8% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.1% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.0% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.1% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.8% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.6% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.7% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.8% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 25,003,233 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,998,733 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,998,733 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,981,199 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,965,786 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 191 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 180 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 179 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 182 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 184 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 57
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2024-04-01 → 2025-03-31 | ¥148m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2024-04-01 → 2025-03-31 | ¥81m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-03-31 | 98 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2025-03-31 | ¥1.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥327m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2025-03-31 | ¥837m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2025-03-31 | ¥132m |
| Nursing Care Service Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥659m |
| Nursing Care Service Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥803m |
| Nursing Care Service Businessreportable segment | employees | at 2025-03-31 | 4744 pure |
| Nursing Care Service Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥55.2bn |
| Nursing Care Service Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥55.2bn |
| Nursing Care Service Businessreportable segment | segment assets | at 2025-03-31 | ¥25.1bn |
| Nursing Care Service Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.6bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥659m |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥803m |
| —segment total | employees | at 2025-03-31 | 4744 pure |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥55.2bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥55.2bn |
| —segment total | segment assets | at 2025-03-31 | ¥25.1bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥807m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥884m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥56.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥56.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥327m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥25.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥1.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2023-04-01 → 2024-03-31 | ¥104m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2023-04-01 → 2024-03-31 | ¥108m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2024-03-31 | ¥1.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥348m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2024-03-31 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2024-03-31 | ¥146m |
| Nursing Care Service Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥971m |
| Nursing Care Service Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥781m |
| Nursing Care Service Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥53.0bn |
| Nursing Care Service Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥53.0bn |
| Nursing Care Service Businessreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥3m |
| Nursing Care Service Businessreportable segment | segment assets | at 2024-03-31 | ¥25.2bn |
| Nursing Care Service Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥2.1bn |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥971m |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥781m |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥53.0bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥53.0bn |
| —segment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥3m |
| —segment total | segment assets | at 2024-03-31 | ¥25.2bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥2.1bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥889m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥54.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥54.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥351m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥26.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥2.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,813
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of investment securities inv cf | Prior1YearDuration | -9975000 | JPY |
| Purchase of investment securities inv cf | CurrentYearDuration | － | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YearDuration | 610000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYearDuration | 492000 | JPY |
| Payments for transfer of business2 inv cf | Prior1YearDuration | － | JPY |
| Payments for transfer of business2 inv cf | CurrentYearDuration | -80848000 | JPY |
| Proceeds from transfer of business inv cf | Prior1YearDuration | 131542000 | JPY |
| Proceeds from transfer of business inv cf | CurrentYearDuration | － | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1YearDuration | － | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | CurrentYearDuration | -120129000 | JPY |
| Payments for merger2 inv cf | Prior1YearDuration | － | JPY |
| Payments for merger2 inv cf | CurrentYearDuration | -6982000 | JPY |
| Subsidies received inv cf | Prior1YearDuration | 77540000 | JPY |
| Subsidies received inv cf | CurrentYearDuration | 185469000 | JPY |
| Payments of loans receivable inv cf | Prior1YearDuration | -2990000 | JPY |
| Payments of loans receivable inv cf | CurrentYearDuration | -2280000 | JPY |
| Collection of loans receivable inv cf | Prior1YearDuration | 5198000 | JPY |
| Collection of loans receivable inv cf | CurrentYearDuration | 2576000 | JPY |
| Payments for guarantee deposits inv cf | Prior1YearDuration | -44227000 | JPY |
| Payments for guarantee deposits inv cf | CurrentYearDuration | -29419000 | JPY |
| Proceeds from collection of guarantee deposits inv cf | Prior1YearDuration | 78558000 | JPY |
| Proceeds from collection of guarantee deposits inv cf | CurrentYearDuration | 83766000 | JPY |
| Other net inv cf | Prior1YearDuration | 12556000 | JPY |
| Other net inv cf | CurrentYearDuration | -71784000 | JPY |
| Net cash provided by used in investment activities | Prior1YearDuration | -715478000 | JPY |
| Net cash provided by used in investment activities | CurrentYearDuration | -993748000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YearDuration | － | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYearDuration | -22000000 | JPY |
| Repayments of finance lease obligations fin cf | Prior1YearDuration | -170066000 | JPY |
| Repayments of finance lease obligations fin cf | CurrentYearDuration | -165006000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1YearDuration | － | JPY |
| Proceeds from long term loans payable fin cf | CurrentYearDuration | 350000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YearDuration | -1149946000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYearDuration | -1024460000 | JPY |
| Purchase of treasury stock fin cf | Prior1YearDuration | － | JPY |
| Purchase of treasury stock fin cf | CurrentYearDuration | -83100000 | JPY |
| Proceeds from exercise of stock option fin cf | Prior1YearDuration | － | JPY |
| Proceeds from exercise of stock option fin cf | CurrentYearDuration | 4000 | JPY |
| Cash dividends paid fin cf | Prior1YearDuration | -592491000 | JPY |
| Cash dividends paid fin cf | CurrentYearDuration | -617591000 | JPY |
| Net cash provided by used in financing activities | Prior1YearDuration | -1912504000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration | -1562153000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YearDuration | 1334029000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration | -835401000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 6687944000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 8021974000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 8021974000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 7186572000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 29 | |
| Number of unconsolidated subsidiaries and associates accounted for using equity method | CurrentYearInstant | 1 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 22 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | mismatch |
| statement vs summary · revenue | mismatch |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |